Enhancing Mother-Child Ties and Psychosocial Wellness Through Arts Among Children With Intellectual Disability and Their Mothers

Launched by THE UNIVERSITY OF HONG KONG · Jan 24, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a special program called Expressive Arts-based Intervention (EXAT) to help improve the relationship and overall well-being of mothers and their children who have intellectual disabilities (ID). The goal is to see if engaging in creative activities like art can help mothers feel less stressed and more connected with their children, while also helping the children express their emotions better. The study will involve 154 mother-child pairs, who will either participate in the arts program or be in a waitlist group where they continue with regular care.

To participate, children need to be between 6 and 12 years old and have a mild to moderate intellectual disability. Both the mother and child must be willing to take part in the study, and they should be able to join group activities. Throughout the trial, participants can expect to engage in enjoyable art activities that aim to strengthen their bond and improve their emotional health. This study not only looks at how the arts help but also gathers personal stories from mothers to understand their experiences better. Your involvement could provide valuable insights into how creative activities can enhance family relationships and support mental wellness.

Gender

ALL

Eligibility criteria

• • Eligible participants are mother-child dyads that fulfill the following inclusion criteria.
• • The child is 6-12 years old (primary school student);
• • The child is diagnosed with mild to moderate ID, IQ score ranges from 35 to 69 (based on the assessment conducted by certified clinicians);
• • By the judgement of the health/school professional staff, the child is capable of responding to assessments and participating in group activities;
• • The dyad is willing and able to give consent for participation.
• Exclusion Criteria:
• • The dyad is currently participating in any other behavioral or pharmacological trial
• • Either member of the dyad have other contraindications or severe comorbidities that may impair their full participation (e.g., severe physical disabilities)